Request for Covid-19 Impact Assessment of this Report
Ferring GmbH
Laboratórios Ferring Ltda
Shire US Inc.
Takeda’s Entyvio
Prescription Hope, Inc
GiCare
Treato
Prasco
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Pentasa tablets
Pentasa granules
Type 3
Split by applications, this report focuses on sales, market share and growth rate of Pentasa in each application, can be divided into
Ulcerative colitis
Crohn's disease
Application 3
United States Pentasa Sales Market Report 2021
1 Pentasa Overview
1.1 Product Overview and Scope of Pentasa
1.2 Classification of Pentasa
1.2.1 Pentasa tablets
1.2.2 Pentasa granules
1.2.3 Type 3
1.3 Applications of Pentasa
1.3.1 Ulcerative colitis
1.3.2 Crohn's disease
1.3.3 Application 3
1.4 USA Market Size (Value and Volume) of Pentasa (2011-2021)
1.4.1 USA Pentasa Sales, Revenue and Price (2011-2021)
1.4.2 USA Pentasa Sales and Growth Rate (2011-2021)
1.4.3 USA Pentasa Revenue and Growth Rate (2011-2021)
2 USA Pentasa Competition by Manufacturers
2.1 USA Pentasa Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Pentasa Revenue and Share by Manufactures (2015 and 2016)
3 USA Pentasa (Volume and Value) by Type
3.1 USA Pentasa Sales and Market Share by Type (2011-2021)
3.2 USA Pentasa Revenue and Market Share by Type (2011-2021)
4 USA Pentasa (Volume) by Application
5 USA Pentasa Manufacturers Analysis
5.1 Ferring GmbH
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Pentasa Product Type and Technology
5.1.2.1 Pentasa tablets
5.1.2.2 Pentasa granules
5.1.3 Pentasa Sales, Revenue, Price of Ferring GmbH (2015 and 2016)
5.2 Laboratórios Ferring Ltda
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharmaceuticals Product Type and Technology
5.2.2.1 Pentasa tablets
5.2.2.2 Pentasa granules
5.2.3 Pharmaceuticals Sales, Revenue, Price of Laboratórios Ferring Ltda (2015 and 2016)
5.3 Shire US Inc.
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Shire US Inc. Product Type and Technology
5.3.2.1 Pentasa tablets
5.3.2.2 Pentasa granules
5.3.3 Shire US Inc. Sales, Revenue, Price of Shire US Inc. (2015 and 2016)
5.4 Takeda’s Entyvio
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Product Type and Technology
5.4.2.1 Pentasa tablets
5.4.2.2 Pentasa granules
5.4.3 Takeda’s Entyvio Sales, Revenue, Price of Takeda’s Entyvio (2015 and 2016)
5.5 Prescription Hope, Inc
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Prescription Hope, Inc Product Type and Technology
5.5.2.1 Pentasa tablets
5.5.2.2 Pentasa granules
5.5.3 Prescription Hope, Inc Sales, Revenue, Price of Prescription Hope, Inc (2015 and 2016)
5.6 GiCare
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 GiCare Product Type and Technology
5.6.2.1 Pentasa tablets
5.6.2.2 Pentasa granules
5.6.3 GiCare Sales, Revenue, Price of GiCare (2015 and 2016)
5.7 Treato
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Treato Product Type and Technology
5.7.2.1 Pentasa tablets
5.7.2.2 Pentasa granules
5.7.3 Treato Sales, Revenue, Price of Treato (2015 and 2016)
5.8 Prasco
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Prasco Product Type and Technology
5.8.2.1 Pentasa tablets
5.8.2.2 Pentasa granules
5.8.3 Prasco Sales, Revenue, Price of Prasco (2015 and 2016)
6 Pentasa Technology and Development Trend
6.1 Pentasa Technology Analysis
6.2 Pentasa Technology Development Trend
7 Research Findings and Conclusion
Figure Picture of Pentasa
Table Classification of Pentasa
Figure USA Sales Market Share of Pentasa by Type in 2015
Figure Pentasa tablets Picture
Figure Pentasa granules Picture
Table Applications of Pentasa
Figure USA Sales Market Share of Pentasa by Application in 2015
Figure Ulcerative colitis Examples
Figure Crohn's disease Examples
Table USA Pentasa Sales, Revenue and Price (2011-2021)
Figure USA Pentasa Sales and Growth Rate (2011-2021)
Figure USA Pentasa Revenue and Growth Rate (2011-2021)
Table USA AAA Sales of Key Manufacturers (2015 and 2016)
Table USA AAA Sales Share by Manufacturers (2015 and 2016)
Figure 2015 AAA Sales Share by Manufacturers
Figure 2016 AAA Sales Share by Manufacturers
Table USA AAA Revenue by Manufacturers (2015 and 2016)
Table USA AAA Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA AAA Revenue Share by Manufacturers
Table 2016 USA AAA Revenue Share by Manufacturers
Table USA AAA Sales and Market Share by Type (2011-2021)
Table USA AAA Sales Share by Type (2011-2021)
Figure Sales Market Share of AAA by Type (2011-2021)
Figure USA AAA Sales Growth Rate by Type (2011-2021)
Table USA AAA Revenue and Market Share by Type (2011-2021)
Table USA AAA Revenue Share by Type (2011-2021)
Figure Revenue Market Share of AAA by Type (2011-2021)
Figure USA AAA Revenue Growth Rate by Type (2011-2021)
Table USA AAA Sales and Market Share by Application (2011-2021)
Table USA AAA Sales Share by Application (2011-2021)
Figure Sales Market Share of AAA by Application (2011-2021)
Figure USA AAA Sales Growth Rate by Application (2011-2021)
Table Ferring GmbH Basic Information List
Table Pentasa Sales, Revenue, Price of Ferring GmbH (2015 and 2016)
Table Laboratórios Ferring Ltda Basic Information List
Table Pentasa Sales, Revenue, Price of Laboratórios Ferring Ltda (2015 and 2016)
Table Shire US Inc. Basic Information List
Table Pentasa Sales, Revenue, Price of Shire US Inc. (2015 and 2016)
Table Takeda’s Entyvio Basic Information List
Table Pentasa Sales, Revenue, Price of Takeda’s Entyvio (2015 and 2016)
Table Prescription Hope, Inc Basic Information List
Table Pentasa Sales, Revenue, Price of Prescription Hope, Inc (2015 and 2016)
Table GiCare Basic Information List
Table Pentasa Sales, Revenue, Price of GiCare (2015 and 2016)
Table Treato Basic Information List
Table Pentasa Sales, Revenue, Price of Treato (2015 and 2016)
Table Prasco Basic Information List
Table Pentasa Sales, Revenue, Price of Prasco (2015 and 2016)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...